• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Measles virus genotyping an important tool in measles outbreak investigation in Norway, 2011

Giuseppe

Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]

Eurosurveillance, Volume 17, Issue 50, 13 December 2012

Surveillance and outbreak reports

Measles virus genotyping an important tool in measles outbreak investigation in Norway, 2011


K Vainio ()<SUP>1</SUP>, T W Steen<SUP>2</SUP>, T M Arnesen<SUP>3</SUP>, K R?nning<SUP>4</SUP>, G ?nestad<SUP>1</SUP>, S Dudman<SUP>1</SUP>
  1. Norwegian Institute of Public Health, Department of Virology, Oslo, Norway
  2. Health and Welfare Authority, City of Oslo, Norway
  3. District of old Oslo, City of Oslo, Norway
  4. Norwegian Institute of Public Health, Department of Infectious Disease Epidemiology, Oslo, Norway
<HR>
Citation style for this article: Vainio K, Steen TW, Arnesen TM, R?nning K, ?nestad G, Dudman S. Measles virus genotyping an important tool in measles outbreak investigation in Norway, 2011. Euro Surveill. 2012;17(50):pii=20340. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20340
Date of submission: 25 April 2012
<HR>This study describes 33 laboratory-confirmed cases of measles that occurred in Norway in 2011, mainly among unvaccinated children between seven months and 10 years of age. Laboratory testing included detection of anti-measles IgM- and IgG antibodies by enzyme-linked immunosorbent assay (ELISA) and molecular detection and characterisation of measles virus by polymerase chain reaction (PCR) and sequencing. Epidemiological data and genotyping revealed that the measles cases originated from eight separate importations, resulting in four outbreaks and four sporadic cases. Except for the first outbreak which affected 18 cases, limited secondary spread occurred in each of the three other outbreaks. The outbreaks were caused by measles virus genotypes B3, D4 and D9, whereas genotypes D8 and B3 were detected in the sporadic cases. This study highlights that genetic characterisation of measles virus is an essential tool in the laboratory surveillance of measles, especially in countries like Norway which are approaching the measles elimination goal. The investigation revealed that importation of measles resulted in subsequent transmission within Norway to non-vaccinated individuals, and twelve cases occurred in healthcare settings, involving both staff and children. The four cases detected among healthcare workers (HCWs) emphasised that the coverage of measles-mumps-rubella (MMR) vaccination among healthcare personnel needs to be improved and both primary and secondary vaccine failure was demonstrated in two fully immunised HCWs.
- ------
 
Back
Top Bottom